juvenile idiopathic arthritis
GPTKB entity
Statements (53)
Predicate | Object |
---|---|
gptkbp:instance_of |
gptkb:juvenile_idiopathic_arthritis
|
gptkbp:advocacy |
gptkb:educational_resources
gptkb:fundraising_events support groups |
gptkbp:affects |
gptkb:children
|
gptkbp:associated_with |
autoimmune disorders
|
gptkbp:clinical_trial |
patient outcomes
ongoing research new treatment options |
gptkbp:community_impact |
varies by region
affects children worldwide |
gptkbp:complication |
joint damage
eye inflammation growth problems |
gptkbp:diagnosis |
blood tests
imaging studies clinical evaluation |
gptkbp:future_prospects |
chronic condition
remission possible requires ongoing care |
gptkbp:historical_context |
first described in 1897
formerly known as Still's disease |
https://www.w3.org/2000/01/rdf-schema#label |
juvenile idiopathic arthritis
|
gptkbp:impact |
quality of life
social activities school attendance |
gptkbp:management |
physical therapy
occupational therapy exercise programs |
gptkbp:premiered_on |
before age 16
|
gptkbp:prevalence |
1 in 1,000 children
|
gptkbp:public_awareness |
gptkb:Juvenile_Arthritis_Awareness_Month
gptkb:National_Arthritis_Awareness_Month |
gptkbp:research_focus |
genetic factors
environmental triggers biologic therapies |
gptkbp:support |
community resources
family involvement pediatric rheumatologists |
gptkbp:symptoms |
stiffness
swelling joint pain lifestyle modifications dietary changes pain relief strategies |
gptkbp:treatment |
corticosteroids
nonsteroidal anti-inflammatory drugs disease-modifying antirheumatic drugs |
gptkbp:type |
systemic
oligoarticular polyarticular |
gptkbp:bfsParent |
gptkb:Skeleton
|
gptkbp:bfsLayer |
4
|